University of Osijek   Report issue

Academic/Hospital Phase 2 Phase 4
Founded: Osijek Croatia (Hrvatska) (1975)

Organization Overview

First Clinical Trial
2013
NCT01860183
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Clinical Hospital Centre Osijek | Department of Otorhinolaryngology and Head and Neck Surgery Osijek | Faculty of Medicine, University of Osijek, Croatia | Josip Juraj Strossmayer University of Osijek | Osijek University Hospital | Osijek University Hospital, J. Huttlera 4, 31 000 Osijek, Croatia | University Hospital Osijek

Active Ingredients

Drugs in Phase 4 Trials (1)

mycophenolate (myfortic) (1 trial)

Drugs in Phase 2 Trials (2)

levobupivacaine (chirocaine) (1 trial)

morphine (1 trial)

Drugs in Other Trials (2)

egg (1 trial)

icosapent ethyl (vascepa) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cognitive Dysfunction (Phase 2)

Femoral Fractures (Phase 2)

Renal Insufficiency (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 5